Current Advances and Hurdles in Chimeric Antigen Receptor Technology
Since tumor-specific T cells were first utilized to treat melanoma patients in 1986 [...]
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-11-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/12/11/3329 |